Global Wealth Strategies & Associates Intellia Therapeutics, Inc. Transaction History
Global Wealth Strategies & Associates
- $279 Billion
- Q2 2024
A detailed history of Global Wealth Strategies & Associates transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Global Wealth Strategies & Associates holds 100 shares of NTLA stock, worth $2,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$2,093
Previous $2.75 Million
18.65%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NTLA
# of Institutions
326Shares Held
88.8MCall Options Held
673KPut Options Held
865K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl11.6MShares$243 Million2.36% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$201 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.1MShares$190 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.8MShares$100 Million3.53% of portfolio
-
State Street Corp Boston, MA4.36MShares$91.3 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $1.59B
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...